Shugo Honda Selected Research

ziconotide (Prialt)

12/2014

Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shugo Honda Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2018
1	Chronic Pain 12/2014
1	Neuralgia (Stump Neuralgia) 12/2014

Drug/Important Bio-Agent (IBA)

3	Gamma Secretase Inhibitors and ModulatorsIBA 01/2020 - 01/2018
3	O-(glucuronic acid 2- sulfate)- (1- - 4)- O- (2,5)- anhydromannitol 6-sulfateIBA 01/2020 - 01/2018
1	imidazopyridineIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	N-Type Calcium Channels (N-Type Calcium Channel)IBA 12/2014
1	ziconotide (Prialt)FDA Link 12/2014

Therapy/Procedure

1	Ligation 12/2014